http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
조아영(Ah-Yeong Cho),허진영(Jin-Young Heo),지승빈(Seung-Bin Ji),박성현(Seong-Hyun Park),공화연(Hwayeon Kong) 한국HCI학회 2023 한국HCI학회 학술대회 Vol.2023 No.2
코로나 사태와 더불어 디지털 의료 시장이 역동적으로 성장하였고 비의료목적의 헬스 케어를 위한 웰니스 (Wellness) 제품부터 의료 목적의 의료기기까지 디지털 치료제가 나날이 떠오르고 있다. 디지털 치료제는 특히 신경계 질환 치료에 효과적이며 생활 습관 교정, 복약 관리 등의 다양한 치료 분야에 활용된다. 더불어 가상현실(VR) 산업 또한 커가면서 VR 기기를 이용한 디지털 치료, 심리 치료에 대한 연구도 활발히 진행되고 있다. 이에 우리는 본 연구에서 VR을 활용한 정신질환 치료에 주목하였다. 일반적으로 정신질환을 치료하는 방법으로는 약물 치료와 상담과 행동 제어를 통한 인지행동치료가 있는데 약물을 이용하면 빠르게 효과를 볼 수 있지만 완벽한 완치를 위해서는 꾸준한 인지행동치료가 꼭 필요하다. 하지만 이런 꾸준한 치료는 많은 시간과 노력이 필요하므로 환자들에게 쉽지 않은 치료임에 분명하다. 우리는 이 치료 방법을 VR 기기와 게 이미피케이션 (Gamification) 요소를 추가한 콘텐츠로 발전시켜 보고자 한다.
( Ji Yeon Kim ),( Gyung Ah Wie ),( Yeong Ah Cho ),( So Young Kim ),( Dae Kyung Sohn ),( Suk Kyoung Kim ),( Mee Duck Jun ) 한국임상영양학회 2018 Clinical Nutrition Research Vol.7 No.4
The enhanced recovery after surgery (ERAS) program aims to maximize the recovery of patients by minimizing pre- and postoperative complications and stress. The program recommends providing preoperative carbohydrate (CHO) supplements and starting an early postoperative diet to reduce the fasting duration. Based on these recommendations, we implemented preoperative CHO supplementation and initiated an early postoperative diet in patients undergoing laparoscopic colorectal resection. We observed 3 patients as follows: a non-ERAS case, preoperative ERAS case, and pre- and postoperative ERAS case. The preoperative well-being and compliance of patients improved after implementation of the ERAS program. Moreover, the length of hospital stay was reduced. Therefore, we consider that the ERAS program may be helpful for the recovery of patients undergoing laparoscopic colorectal resection.
간호학 전공 대학생의 임상 실습 관련 교육 어플리케이션에 대한 사용의도의 영향요인에 대한 연구
조윤정,김영순,박계영,김혜림,최일향,강보영,백진아,정수진,전영지,정연주 이화여자대학교 간호과학대학 2015 이화간호학회지 Vol.- No.49
Purpose: This study examined perceptions and intentions of nursing undergraduates to use educational mobile applications for clinical nursing-practice training. Methods: Participants were 189 junior and senior nursing undergraduates from 14 Korean universities, experienced in clinical practice and educational nursing mobile applications. Using a convenience sampling method, the questionnaire was Sim’s Perceptions and Intentions tool. Statistical analyses were conducted by t-test, one-way ANOVA, correlation, and multiple regression analysis with SPSS 22.0 Windows software. Results: Statistically significant differences emerged between those who used smartphones for more than 4 hours (18.56 ± 4.58) and less than 2 hours (15.84 ± 4.35) per day (F = 3.25, p = .041). Perception and intention of educational-applications use correlated positively (r = .723, p < .001). Performance expectancy (β = .225, p = .002), attitude toward technology (β = .446, p < .001), facilitating condition (β = .132, p = .022), and self-efficacy (β = .168, p = .008) were statistically significant predictors of intention to use educational mobile applications (Adjusted R2 =.616, p < .001). Conclusion: Attitude toward using technology, performance expectancy, and self-efficacy will improve use of nursing educational mobile applications for clinical nursing-practice training. Developers should consider students’ experience in clinical-nursing practice and readiness to use mobile technology.
Ah Young Cho,Su Yeong Ko,Jae Hee Lee,Eun Young Kim 대한소아내분비학회 2020 Annals of Pediatirc Endocrinology & Metabolism Vol.25 No.1
Purpose: The clinical significance of birth weight relative to gestational age in girls with central precocious puberty is unclear. This study sought to compare clinical parameters such as final adult height (FAH) and menarche onset after treatment with gonadotropin-releasing hormone agonist (GnRHa) on birth weight in girls with central precocious puberty treated. Methods: This retrospective study reviewed data of 69 girls with precocious puberty who had reached their FAH in a long-term trial of GnRHa treatment between January 2007 and December 2017. The subjects were divided into small for gestational age (SGA) (n=19) and appropriate for gestational age (AGA) (n=50) groups. Results: When starting GnRHa treatment, bone age was 10.9±0.9 and 10.3±0.8 years in the SGA and AGA groups, respectively (P<0.05). The predicted adult height (PAH) (established according to the Bayley-Pinneau average table) and advanced PAH (established according to the Bayley-Pinneau advanced table) were 151.5±4.8 cm and 155.8±4.9 cm in the SGA group, respectively, and 153.4±5.3 cm and 159.0±6.0 cm in the AGA group. After treatment, no significant difference in bone age was found between the groups. The time to menarche after treatment was 12.5±7.6 and 21.1±12.3 months in the SGA and AGA groups, respectively (P<0.05). FAH in the SGA and AGA groups was 161.0±4.7 cm and 161.6±5.0 cm, respectively, without a significant difference. Conclusion: SGA girls with precocious puberty have increased bone age and earlier menarche relative to AGA girls. However, no difference in FAH after treatment was found between these groups.
Cho Ah Young,Ko Su Yeong,Lee Jae Hee,Kim Eun Young 대한소아내분비학회 2021 Annals of Pediatirc Endocrinology & Metabolism Vol.26 No.4
Purpose: There are few reports on the therapeutic effects of gonadotropin-releasing hormone agonists in boys with central precocious puberty, and studies reported in Korea are very rare. We aimed to assess the significance of clinical factors and the effects of gonadotropin-releasing hormone agonist treatment on final adult height in boys diagnosed with central precocious puberty.Methods: We retrospectively evaluated the medical records of 18 boys treated for idiopathic central precocious puberty between 2007 and 2018 at Chosun University Hospital. Gestational age, birth weight, and parental height were assessed at the initial visit. Chronological age, bone age, bone age/chronological age ratio, height and height standard deviation scores, predicted adult height, body mass index, and hormone levels were assessed during the treatment period.Results: At the time of diagnosis, the chronological age was 9.9±0.6 years, the bone age was 11.6±1.0 years, and the bone age/chronological age ratio was 1.20±0.1. The bone age/chronological age ratio decreased significantly to 1.12±0.1 at the end of treatment (P<0.05). The luteinizing hormone/follicular stimulating hormone ratios were 3.4±1.2, 0.6±0.4, and 0.6±1.0 at the start of treatment, after 1 year of treatment, and at the end of treatment, respectively. After gonadotropin-releasing hormone agonist treatment, the final adult height reached 172.0±4.8 cm compared to the target height range of 171.0±4.0 cm.Conclusion: In boys with central precocious puberty, gonadotropin-releasing hormone agonist treatment improved growth potential.
Cho, Pyung Goo,Ji, Gyu Yeol,Ha, Yoon,Lee, Hye Yeong,Shin, Dong Ah ELSEVIER 2019 SPINE JOURNAL Vol.19 No.6
<P><B>Abstract</B></P> <P><B>BACKGROUND CONTEXT</B></P> <P>Posterolateral fusion (PLF) with autogenous iliac bone graft is one of the most common surgical procedures for lumbar spinal disease. However, its limited success demands new biologically competent graft enhancers or substitutes. Although the use of direct current (DC) electrical stimulation has been shown to increase rate of successful spinal fusions, little is known about the effect of the type of current in DC stimulation.</P> <P><B>PURPOSE</B></P> <P>To evaluate the effects of various DC stimulators on the strength and success rate of posterolateral fusion facilitated by using a nitinol mesh container, in rats.</P> <P><B>STUDY DESIGN</B></P> <P>This was an experimental animal study.</P> <P><B>METHODS</B></P> <P>A conductive, tubular nitinol mesh container was used to carry small pieces of bone grafts. The nitinol mesh container received electrical stimulation via a lead that connected the container to different types of DC stimulators. Sixty male Sprague-Dawley rats were divided into three groups (N=20 in each): a control group that underwent PLF with a nitinol container filled with autograft, a constant DC group that received a nitinol container and constant DC (100 μA), and a pulsed DC group that received a nitinol container and pulsed DC (100 μA, 100 Hz, 200 μs). The rats underwent PLF between L4 and L5, and transverse processes were grafted with bilateral iliac grafts. A stimulator was implanted subcutaneously. The rats were sacrificed 8 weeks postsurgery, and lumbar spines were removed. Spinal fusion was evaluated by microcomputed tomography, manual testing, biomechanical testing, histologic examination, and molecular analysis.</P> <P><B>RESULTS</B></P> <P>All animals in the DC stimulation groups displayed solid fusion, whereas only 70% of control animals showed solid fusion. Radiographic images, biomechanical testing, histologic examination, and molecular analysis revealed improved fusion in the order control group<constant DC group<pulsed DC group. The volume of new bone mass was significantly higher in the pulsed DC group (p<.05). Fusion was more solid in the pulsed DC group than in control group (p<.05). The pulsed DC group displayed the lowest inflammatory responses.</P> <P><B>CONCLUSIONS</B></P> <P>Pulsed DC electrical stimulation is efficacious in improving both strength and fusion rate in a rat spinal fusion model. In addition, tubular nitinol mesh, made of conductive suture, appears useful for holding small pieces of bone grafts and maintaining a good environment for bone fusion.</P> <P><B>CLINICAL RELEVANCE</B></P> <P>Pulsed DC electrical stimulation may be potentially useful to increase the fusion rate after spinal fusion in humans. Future research is required to evaluate the safety and efficacy of tubular nitinol mesh and pulsed DC electrical stimulation in humans.</P>